ribavirin

(redirected from Rebetol)
Also found in: Thesaurus, Medical.
Related to Rebetol: ribavirin, Ribasphere, Copegus, PegIntron

ri·ba·vi·rin

 (rī′bə-vī′rĭn)
n.
A synthetic antiviral ribonucleoside that inhibits DNA and RNA replication, used to treat lung infections caused by respiratory syncytial virus in infants and young children and in combination with an interferon to treat hepatitis C infection.

[Probably rib(onucleic) a(cid) + vir(us) + -in.]

ribavirin

(ˈriːbəˌvaɪrɪn)
n
(Medicine) an antiviral drug used against many viruses such as influenza, and, in combination with other drugs, hepatitis C

ri•ba•vi•rin

(ˈraɪ bəˌvaɪ rɪn)

n.
a synthetic compound, C8H12N4O5, active against several DNA and RNA viruses.
[1965–70; probably by shortening and alter. of ribofuranosyl, a component of its chemical name (see ribose, furan, -ose2, -yl) + vir (us) + -in1]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.ribavirin - an inhaled antiviral agent (trade name Virazole) that may be used to treat serious virus infections
antiviral, antiviral agent, antiviral drug - any drug that destroys viruses
Translations

ribavirin

n ribavirina
References in periodicals archive ?
Ombitasvir-paritaprevirritonavir plus dasabuvirvir* Viekira Pak XR Quetiapine-Seroquel Ribavirin * Rebetol
Sovaldi is usually given with ribavirin (Xolox, Copegus, Rebetol, Ribasphere, Riba Tab) with or without peginter feronalfa (Pegasys, PegIntron).
Idenix currently has three hepatitis C drugs in clinical development, and Merck markets three hepatitis C medications: Victrelis, PegIntron and Rebetol.
telaprevir (Incivek, Vertex Pharmaceuticals), an HCV genotype-1 protease inhibitor, combined with peginterferon alfa-2a (Pegasys, Genetech) plus ribavirin (Copegus, Genetech; Rebetol, Merck; etc.
Boceprevir, in combination with PEGINTRON (peginterferon alfa-2b) and REBETOL (ribavirin, USP) (Peg/riba), is being studied for the treatment of patients with HCV genotype 1 infection who were previously treated (treatment-failure; HCV RESPOND-2) and in patients who are new to treatment (treatment-naive; HCV SPRINT-2).
In both trials, patients also took two older drugs, Pegintron and Rebetol, along with either the boceprevir or a placebo.
Table 2 Drugs for the Treatment of Chronic Hepatitis C Immunomodulators Interferon alfa-2a (Roferon[R], Roche Pharmaceuticals) interferon alfa-2b (Intron A[R], Schering Corporation) Interferon alfacon-1 (Infergen[R], Valeant Pharmaceuticals) Peginterferon alfa-2a (Pegasys[R], Roche Pharmaceuticals) Peginterferon alfa-2b (PegIntron[R], Schering Corporation) Antiviral Ribavirin (Copegus, Rebetol, Ribasphere, and other manufacturers) Drugs Currently in Advanced Stages of Development * Albinterferon alfa-2b (Albuferon[R], Human Genome Sciences, Inc.
The company is a global leader in treatments for hepatitis C with its PEG-Intron, a onceweekly alpha interferon, combined with the Rebetol antiviral agent.
That plant makes Zetia, for cholesterol control; Clarinex, an allergy medication; and Rebetol, for hepatitis B.
2) With the approval of Peg-Intron and Rebetol combination therapy in Japan in late 2004, sales of ribavirin increased from $18.
FDA approves Rebetol (ribavarin) oral solution for treatment of children with chronic hepatitis C.
The first FDA-approved therapy for children with hepatitis C, Rebetol Oral Solution (ribavirin), is now available.